Tag: <span>Mesothelioma News</span>

ABI ‘Frustrated’ by Judgment Applying LASPO to Mesothelioma Claims

A recent decision by the UK’s High Court to apply Legal Aid, Sentencing and Punishment of Offenders Act to mesothelioma claims has triggered a negative response from the Association of British Insurers . James Dalton, the ABI’s Head of Motor and Liabil…

Mesothelioma Victim Awarded $7 Million for Asbestos Exposure in ’60s

Jury Finds National Grid Liable, Awards $7 Million to Plaintiff in Asbestos Exposure Case

Family of tragic postman call for more research into deadly disease

THE family of a postman who died of a deadly asbestos cancer has called for more research into the deadly disease. Tony Holt, whose uncle Terence McCarthy died from mesothelioma at Bolton Hospice , attended a meeting addressed by Kate Green MP, shadow …

Subchronic Inhalation Exposure of Rats to Libby Amphibole and Amosite …

EPA Home A Science Inventory A Subchronic Inhalation Exposure of Rats to Libby Amphibole and Amosite Asbestos: Effects at 18 Months Post Exposure### Willson, G., D. Dodd, K. Roberts, H. Wall, AND S. Gavett. Subchronic Inhalation Exposure of Rats to Lib…

Direct targeting and induction of immunological attacks on cancer cells

Direct targeting and induction of immunological attacks on cancer cells are two widely used approaches for the treatment of cancer. But Professor Hiromi Kumon and colleagues at Okayama University have developed a third and potentially more effective ap…

Studies report new findings on treatment options for mesothelioma

Treating patients with high-dose radiotherapy after chemotherapy and surgery for malignant pleural mesothelioma does not achieve improvements in local relapse and overall survival, according to…

Studies report new findings on treatment options for mesothelioma

Treating patients with high-dose radiotherapy after chemotherapy and surgery for malignant pleural mesothelioma does not achieve improvements in local relapse and overall survival, according to data from a prospective randomized phase II trial presente…